Delivery Order SPE2DB20D2104-SPE2DB22FT97J

Award Date 9/19/22
Potential Completion Date 9/20/22
Potential Value $1.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Emgality 120 mg/ml pen injectors to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,476.82 firm-fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on August 31, 2023. The contract has a completion date of September 1, 2023 and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
This federal contract award is for the delivery of Emgality 120 mg/ml pen injectors to the Defense Logistics Agency (DLA), a defense agency of the U.S. Department of Defense. The contract, valued at $3,175.43, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract has no set-aside designation and is a Firm Fixed Price Delivery Order with an ultimate completion date of June 18, 2024. Amerisourcebergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,739.03, is for the supply of Emgality 120 mg/ml pen injectors. It is a firm fixed-price contract with an ultimate completion date of April 13, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract, valued at $4,837.76, is for the delivery of Emgality 120 mg/mL pen injectors, a prescription medication. This contract award is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) for the delivery of Emgality 120 mg/ml pens. The contract has a ceiling value of $2,593.50 and is a firm fixed-price delivery order with a completion date of January 15, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $1,097.06 firm fixed-price delivery order is for the pharmaceutical product Emgality 120 mg/ml penml. The contract has a completion date of September 6, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) to supply a wide range of medications and medical supplies...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,209.44 Firm Fixed Price Delivery Order is for the supply of the pharmaceutical product Emgality 120 mg/ml pen. The contract has an ultimate completion date of June 21, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,642.29 firm-fixed-price delivery order is for the supply of Emgality 120 mg/ml pen-injectors, a prescription medication used for the treatment of migraine. The award has an ultimate completion date of November 13, 2024 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Emgality 120 mg/ml pens. The contract has a ceiling value of $1,729 and was awarded by the Defense Logistics Agency (DLA), a defense agency, on February 3, 2025, with a final completion date of February 4, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp (DUNS: TGxsdkVQRGhOYUpNR001SFhYREdNdz09) was issued by the Defense Logistics Agency (DLA) for the delivery of Emgality 120 mg/ml Pen. The $1,002.72 firm-fixed-price delivery order has a period of performance through September 17, 2024 and is not designated as a set-aside contract. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor on this award, which is a child contract under a larger Indefinite Delivery...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB22FT97J
    Delivery Order

This federal contract award is for the delivery of Emgality 120 mg/mL pen-injectors to the Defense Logistics Agency (DLA). The $1,097.14 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc.

The contract has an ultimate completion date of September 20, 2022 and was awarded on September 19, 2022. It does not have a set-aside designation, indicating open competition.

AmerisourceBergen is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, providing a wide range of pharmaceutical products and medical supplies to support military and veterans' healthcare programs globally. The company also has a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities.

Generated 2/27/25, 10:11 AM